 <h1>Argatroban Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to argatroban: intravenous solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, argatroban may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking argatroban:</p><p>
<i>More common</i>
</p><ul>
<li>Bleeding from the bladder</li>
<li>blood in the urine</li>
<li>blurred vision</li>
<li>chest pain</li>
<li>confusion</li>
<li>dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly</li>
<li>fever</li>
<li>no blood pressure or pulse</li>
<li>stopping of heart</li>
<li>sweating</li>
<li>unconsciousness</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Arm, back, or jaw pain</li>
<li>bloody or black, tarry stools</li>
<li>chest tightness or heaviness</li>
<li>constipation</li>
<li>cough or hoarseness</li>
<li>coughing or spitting up blood</li>
<li>fast, slow, or irregular heartbeat</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>lower back or side pain</li>
<li>nausea</li>
<li>pain or discomfort in the arms, jaw, back, or neck</li>
<li>painful or difficult urination</li>
<li>palpitations</li>
<li>severe stomach pain</li>
<li>shortness of breath</li>
<li>sweating</li>
<li>vomiting</li>
<li>vomiting of blood or material that looks like coffee grounds</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Abdominal pain or swelling</li>
<li>back pain or backaches</li>
<li>blue lips and fingernails</li>
<li>changes in skin color</li>
<li>cold hands and feet</li>
<li>coughing that sometimes produces a pink frothy sputum</li>
<li>diarrhea</li>
<li>difficult, fast, noisy breathing, sometimes with wheezing</li>
<li>increased sweating</li>
<li>indigestion</li>
<li>loss of appetite</li>
<li>pain, redness, or swelling in the arm or leg</li>
<li>pains in the chest, groin, or legs, especially calves of the legs</li>
<li>pale skin</li>
<li>passing of gas</li>
<li>severe headaches of sudden onset</li>
<li>stomach pain, fullness, or discomfort</li>
<li>sudden loss of coordination</li>
<li>sudden onset of shortness of breath for no apparent reason</li>
<li>sudden onset of slurred speech</li>
<li>sudden vision changes</li>
<li>swelling in the legs and ankles</li>
</ul><p>
<!-- end intravenous solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to argatroban: intravenous solution</i></p><h3>Hematologic</h3><p>Hematologic side effects including overt bleeding or hemorrhage are the most common complications of argatroban therapy.  Major hemorrhagic events reported by the manufacturer include gastrointestinal bleeding (2.3%), intracranial bleeding (about 1% in patients receiving both argatroban and thrombolytic therapy), genitourinary bleeding and hematuria (0.9%), decreases in hemoglobin/hematocrit (0.7%), multisystem hemorrhage/DIC (0.5% ), and limb/below the knee amputation (0.5%).  Minor hemorrhagic events reported by the manufacturer include gastrointestinal bleeding (14.4%), genitourinary bleeding and hematuria (11.6%), minor decreases in hemoglobin/hematocrit (10.4%), groin bleeding (5.4%), hemoptysis (2.9%), brachial bleeding (2.4%).<sup>[Ref]</sup></p><p>In a study of patients given argatroban for the treatment of heparin-induced thrombocytopenia or heparin-induced thrombocytopenia and thrombosis syndrome, one patient experienced intracranial hemorrhage 4 days after the discontinuation of argatroban therapy and following urokinase and oral anticoagulation therapy.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Cardiovascular side effects include hypotension (7.2%), cardiac arrest (5.8%), ventricular tachycardia (4.8%), atrial fibrillation (3.0%) and cerebrovascular disorder (2.3%).<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Gastrointestinal side effects include diarrhea (6.2%), nausea (4.8%), vomiting (4.2%), and abdominal pain (2.6%).<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Respiratory effects include dyspnea (8.1%), pneumonia (3.3%) and coughing (2.8%).<sup>[Ref]</sup></p><h3>General</h3><p>General side effects include fever (6.9%), sepsis (6.0%) and pain (4.6%).<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Genitourinary side effects include urinary tract infection (4.6%).<sup>[Ref]</sup></p><h3>Immunologic</h3><p>Immunological side effects include infection (3.7%).<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Acova (argatroban)" SmithKline Beecham, Philadelphia, PA. </p><p id="ref_2">2. Swan SK, St. Peter JV, Lambrecht LJ, Hursting MJ "Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects." Pharmacotherapy 20 (2000): 756-70</p></div>
<div class="more-resources" id="moreResources">
<h2>More about argatroban</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: thrombin inhibitors</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Argatroban Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Thrombotic/Thromboembolic Disorder</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to argatroban: intravenous solution</i></p><h3>Hematologic</h3><p>Hematologic side effects including overt bleeding or hemorrhage are the most common complications of argatroban therapy.  Major hemorrhagic events reported by the manufacturer include gastrointestinal bleeding (2.3%), intracranial bleeding (about 1% in patients receiving both argatroban and thrombolytic therapy), genitourinary bleeding and hematuria (0.9%), decreases in hemoglobin/hematocrit (0.7%), multisystem hemorrhage/DIC (0.5% ), and limb/below the knee amputation (0.5%).  Minor hemorrhagic events reported by the manufacturer include gastrointestinal bleeding (14.4%), genitourinary bleeding and hematuria (11.6%), minor decreases in hemoglobin/hematocrit (10.4%), groin bleeding (5.4%), hemoptysis (2.9%), brachial bleeding (2.4%).<sup>[Ref]</sup></p><p>In a study of patients given argatroban for the treatment of heparin-induced thrombocytopenia or heparin-induced thrombocytopenia and thrombosis syndrome, one patient experienced intracranial hemorrhage 4 days after the discontinuation of argatroban therapy and following urokinase and oral anticoagulation therapy.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Cardiovascular side effects include hypotension (7.2%), cardiac arrest (5.8%), ventricular tachycardia (4.8%), atrial fibrillation (3.0%) and cerebrovascular disorder (2.3%).<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Gastrointestinal side effects include diarrhea (6.2%), nausea (4.8%), vomiting (4.2%), and abdominal pain (2.6%).<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Respiratory effects include dyspnea (8.1%), pneumonia (3.3%) and coughing (2.8%).<sup>[Ref]</sup></p><h3>General</h3><p>General side effects include fever (6.9%), sepsis (6.0%) and pain (4.6%).<sup>[Ref]</sup></p><h3>Genitourinary</h3><p>Genitourinary side effects include urinary tract infection (4.6%).<sup>[Ref]</sup></p><h3>Immunologic</h3><p>Immunological side effects include infection (3.7%).<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Acova (argatroban)" SmithKline Beecham, Philadelphia, PA. </p><p id="ref_2">2. Swan SK, St. Peter JV, Lambrecht LJ, Hursting MJ "Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects." Pharmacotherapy 20 (2000): 756-70</p><h2>More about argatroban</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: thrombin inhibitors</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Argatroban Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Thrombotic/Thromboembolic Disorder</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>